China CAS:223673-61-8 Manufacturer

June 2019
CPhI is the undisputed leader in the pharmaceutical industry. CPhI China offers a key access point to the second largest pharma market in the world. The exhibition features over 3,000 companies and incorporates various API showcases like bioLIVE, iCSE, NEX and FDF, creating a comprehensive platform that connects the entire pharmaceutical industry chain in the Asian-Pacific region.

From June 19 to 21, the 22nd World Pharmaceutical Raw Materials China Exhibition (CPHI China 2024), organized by Informa Markets and China Chamber of Commerce for Import and Export of Pharmaceutical and Health Products and co-organized by Shanghai Bohua International Exhibition Co., LTD., was held in Shanghai. Nearly 3,500 well-known exhibitors at home and abroad gathered in Shanghai New International Expo Center (Pudong), attracting more than 60,000 professional buyers from more than 150 countries and regions, and a total of more than 90,000 industry colleagues to participate in the event.

CPhI Korea 2024 will be held at COEX, Seoul Hall A from August 27 to 29, our booth number is M27.

CPHI Middle East 2024 will be held in Riyadh from 10 Dec 2024 - 12 Dec 2024. The pavilion is located at Riyadh Front Exhibition & Convention Center Riyadh and our booth number is 3.G43.

At Humanwell, our two decades of experience are dedicated to mastering these very compounds. We understand that the purity, stability, and reliability of every Intermediates Category directly determine the safety, efficacy, and scalability of the final drug. This blog will delve into the indispensable role these molecules play and how Humanwell ensures your manufacturing process is built on a foundation of excellence.

When buyers search for an Intermediates Category supplier, they are rarely looking for a catalog page alone. They want consistency, traceability, dependable scale-up, and confidence that every stage before the final active ingredient has been handled with discipline.